文献速递其他结缔组织病

快速就诊策略对疑似风湿性多肌痛转诊率、诊断及糖皮质激素起始的影响

Impact of a rapid access strategy on referral rates, diagnosis, and glucocorticoid initiation in suspected polymyalgia rheumatica.
PubMed 文献 · Semin Arthritis Rheum · 2025-07-17

该单中心回顾性队列研究比较疑似风湿性多肌痛患者经快速就诊策略(RAS)门诊与历史队列的转诊率、评估时间、诊断及评估前糖皮质激素起始情况。RAS实施后转诊率几乎翻倍,评估时诊断为风湿性多肌痛的比例为70%(95%CI:62-77) vs 历史队列59%(95%CI:52-65),评估前起始糖皮质激素者9%(95%CI:6-13) vs 20%(95%CI:15-28),诊断后一年仍使用糖皮质激素者50%(95%CI:39-61) vs 77%(95%CI:62-89)。

要点

  • RAS门诊实施后疑似风湿性多肌痛转诊率几乎翻倍。
  • RAS队列评估时诊断为风湿性多肌痛比例为70%(95%CI:62-77),历史队列为59%(95%CI:52-65)。
  • RAS队列评估前起始糖皮质激素者9%(95%CI:6-13),低于历史队列的20%(95%CI:15-28)。

核心结论

  • 实施针对疑似风湿性多肌痛患者的RAS门诊提高了转诊率,同时适度降低了评估时诊断为风湿性多肌痛的比例,并降低了评估前起始糖皮质激素的患者比例。

研究设计与样本

  • 单中心回顾性队列研究,比较转诊至RAS门诊的疑似风湿性多肌痛患者与历史队列,比较转诊率、从转诊至评估的时间、诊断及评估前糖皮质激素起始情况。

主要发现

  • RAS门诊实施后转诊率几乎翻倍,评估时诊断为风湿性多肌痛的比例为70%(95%CI:62-77) vs 历史队列59%(95%CI:52-65)。
  • RAS队列在1周内完成评估者55%(95%CI:49-62) vs 历史队列36%(95%CI:28-44),在2周内完成评估者89%(95%CI:84-92) vs 历史队列75%(95%CI:67-81)。
  • RAS队列评估前起始糖皮质激素者9%(95%CI:6-13) vs 历史队列20%(95%CI:15-28)。
  • RAS队列诊断后一年仍接受糖皮质激素者50%(95%CI:39-61) vs 历史队列77%(95%CI:62-89)。
  • 亚临床巨细胞动脉炎的比例仍然较低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Diagnosing polymyalgia rheumatica (PMR) is difficult, and 50 % have initiated glucocorticoids (GC) before rheumatological evaluation, challenging the distinction from other conditions. Rapid access strategy (RAS) clinics for individuals with suspected PMR may reduce GC initiation before rheumatological evaluation, but evidence is limited. This study evaluates the impact of a RAS clinic compared with a traditional referral approach for individuals with suspected PMR. METHODS: This single-centre retrospective cohort study compared individuals suspected of PMR referred to a RAS clinic with a historical cohort. Comparisons included referral rates, time from referral to evaluation, diagnosis, and GC initiation before evaluation. RESULTS: Referral rates almost doubled after the RAS clinic was implemented with modest change in the proportion diagnosed with PMR at evaluation (70 % [95 % CI: 62-77] vs. 59 % [95 % CI: 52-65]). Compared with the historical cohort, more individuals in the RAS cohort were evaluated within one week (55 % [95 % CI: 49-62] vs. 36 % [95 % CI: 28-44]) and two weeks (89 % [95 % CI: 84-92] vs. 75 % [95 % CI: 67-81]). Additionally, fewer individuals initiated GCs before evaluation (9 % [95 % CI: 6-13] vs. 20 % [95 % CI: 15-28]) and fewer patients received GCs one year after diagnosis (50 % [95 % CI: 39-61] vs. 77 % [95 % CI: 62-89]). The proportion with subclinical giant cell arteritis remained low. CONCLUSION: Implementation of a RAS clinic for individuals with suspected PMR increased referral rates, while modestly reducing the proportion diagnosed with PMR, and lowered the proportion of individuals initiating GCs before evaluation.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Nielsen EL, Nielsen AW, Donskov AO, et al. Impact of a rapid access strategy on referral rates, diagnosis, and glucocorticoid initiation in suspected polymyalgia rheumatica. Semin Arthritis Rheum. 2025. PMID: 40729826. doi:10.1016/j.semarthrit.2025.152793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。